Augustina Isioma Ikusemoro: Why Routine Platelet Transfusion Is Not Always Recommended in Dengue
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“In Dengue, low platelets alone are not the enemy – poor clinical judgment is.
One of the most common misconceptions in dengue management is:
‘Low platelet count equals automatic platelet transfusion.’
But the science says otherwise.
Platelet transfusion in dengue is not routine treatment.
Dengue bleeding is not driven by thrombocytopenia alone.
It is also caused by:
- Increased capillary leak
- Platelet dysfunction
- Bone marrow suppression
- Coagulopathy and plasma leakage
So the real question is not:
‘What is the platelet count?’
The better question is:
‘What is the patient’s clinical condition?’
When should platelet transfusion be considered?
- Active or significant bleeding
- Severe thrombocytopenia in selected high-risk patients
- Falling platelet counts with warning signs
- Before invasive procedures when clinically indicated
But in a stable patient without bleeding?
Routine prophylactic platelet transfusion is usually not recommended – even when platelet counts are low.
Why?
Because unnecessary transfusions can lead to:
- Transfusion reactions
- Volume overload
- Wastage of a precious blood resource
The key lesson?
Treat the patient – not just the platelet count.
In transfusion medicine, wisdom is knowing when not to transfuse.
Think clinical. Assess risk. Transfuse wisely. Save lives.
Signature of Blood Doki
Educate. Empower. Elevate.
Better Blood. Better Care. Better Outcomes.”
Find more posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
May 27, 2026, 13:56Suzan Osman: The Major Types of Intracranial Hemorrhage in Clinical Practice
-
May 27, 2026, 13:55Raimundo C. Santos: The Main Aggressors of the Aorta and What These Lead to
-
May 27, 2026, 13:54Pooja Choradia: 2026 Acute Pulmonary Embolism Clinical Guidelines
-
May 27, 2026, 13:53Rehab Hussein: Blood Bank Training and the Clinical Responsibility of Preserving Human Life
-
May 27, 2026, 13:42New EAS Consensus Highlights Advances in Pediatric FH Care
-
May 27, 2026, 13:10Amos Gitonga Mbaabu: Global Partnerships Supporting Hemophilia and Sickle Cell Care in Africa
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome